Analysis of the active compounds of Panax notoginseng and Panax ginseng in Kangerxin capsules
Y Wang
Abstract
Y Wang
Abstract
Objective To analyze the active compounds of Panax notoginseng and Panax ginseng in Kangerxin capsules. Methods HPLC was used to analyze the contents of ginsenoside Rg1 and Rb1, notoginsenoside Rl in Kangerxin capsules. Results The linear ranges of ginsenoside Rg1, ginsenoside Rb1, notoginsenoside R1 were0.0396~0.1584μg, 0.04076~0.16304μg and 0.0412~0.1648μg with average recoveries of 100.20% (RSD=0.38%) , 100.13% (RSD=0.39%) and 99.68% (RSD=0.36%) , respectively. Conclusion The method is simple, reliable and stable, which could be used for the quality control of Kangerxin capsules.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To analyze the active compounds of Panax notoginseng and Panax ginseng in Kangerxin capsules. Methods HPLC was used to analyze the contents of ginsenoside Rg1 and Rb1, notoginsenoside Rl in Kangerxin capsules. Results The linear ranges of ginsenoside Rg1, ginsenoside Rb1, notoginsenoside R1 were0.0396~0.1584μg, 0.04076~0.16304μg and 0.0412~0.1648μg with average recoveries of 100.20% (RSD=0.38%) , 100.13% (RSD=0.39%) and 99.68% (RSD=0.36%) , respectively. Conclusion The method is simple, reliable and stable, which could be used for the quality control of Kangerxin capsules.
Key concepts: Panax notoginseng, Ginseng, Ginsenoside Rg1, Medicine, Traditional medicine, Ginsenoside, Araliaceae, Chromatography